Date |
Research Question / Title |
Unique ID |
Research Team |
September 17, 2020
|
What evidence is there to support medical exemptions for mask wearing?
|
EOC091101 RR
|
EOC
|
December 1, 2020
|
What is the evidence for the effectiveness of universal mask use by the public? [Update]
|
EOC062301v3 RR
|
EOC
|
December 17, 2020
|
How is COVID-19 transmitted from person-to-person and what is the most common source of transmission?
|
INF121501 RR
|
Infectious Disease
|
January 11, 2021
|
What public health interventions are effective in reducing the burden of COVID-19 disease in comparable jurisdictions to Saskatchewan?
|
PH111001 RR
|
Public Health
|
January 19, 2021
|
How are other jurisdictions distributing COVID-19 vaccines in non-healthcare worker environments and what is the rationale for those distribution models?
|
PH011401 RR
|
Public Health
|
March 12, 2021
|
What are the vaccination strategies for vulnerable populations?
|
PH030401 RR
|
Public Health
|
March 18, 2021
|
What are the differences between COVID-19 vaccines and how should they be distributed based on population group(s)?
|
EOC031001 RR
|
EOC
|
April 21, 2021
|
What are the risks or benefits of extended intervals between doses of COVID-19 vaccines compared to recommended dosing in extremely vulnerable populations?
|
EOC210302 RR
|
EOC
|
June 21, 2021
|
What are the ethical/legal aspects of vaccine requirements?
|
EOC210503 RR
|
EOC
|
October 7, 2021
|
What is the current evidence and recommendations regarding COVID-19 vaccine booster shots (exceeding 2 doses) for the general population?
|
EOC210902 RR
|
EOC
|
December 20, 2021
|
What is the epidemiology of variants and what are the implications for healthcare? [Evergreen]
|
EOC031801v019 RR
|
EOC
|
December 26, 2021
|
How effective are COVID-19 vaccines? [Evergreen]
|
INF031801v019 RR
|
Infectious Disease
|
December 22, 2021
|
What is the epidemiology of the Omicron variant and its impact on health care?
|
EOC211220 RR
|
EOC
|
January 12, 2022
|
In real world settings, what is the validity of Rapid Antigen Tests (RATs) in identifying SARS-CoV-2 and how well do they predict disease?
|
EOC211201 RR
|
EOC
|
February 4, 2022
|
What are the harmful/adverse effects of multiple doses of COVID-19 mRNA vaccines?
|
EOC220103 RR
|
EOC
|
February 10, 2022
|
What is the (case) definition of hospitalization for COVID-19 in similar jurisdictions?
|
CAC220101 RR
|
Clinical/Acute Care
|
March 10, 2022
|
What is the safety/efficacy of the Novavax COVID-19 vaccine?
|
EOC220302 RR
|
EOC
|
March 31, 2022
|
What is the incidence and duration of long COVID cases?
|
EPM210601v2 RR
|
Epidemiology & Modelling
|
May 2022
|
Motivational Interviewing for Vaccine Hesitancy - Situation, Background, Assessment, Recommendation (SBAR)
|
EOC220301 SBAR
|
EOC
|
June 6, 2022
|
What is known about hybrid immunity to COVID-19?
|
INF220501 RR
|
Infectious Disease
|